| | Measured outcome | High-target group () | Low-target group () | value |
| | Gestational age at delivery () | | | 0.413 | | <37 weeks (, %) | 37 (9.3%) | 18 (8.7%) | 0.78 | | ≥37 weeks (, %) | 359 (90.7%) | 190 (91.3%) | 0.78 | | Cesarean delivery (, %) | 153 (38.6%) | 77 (37.0%) | 0.698 | | Cesarean, intrapartum (, %) | 61 (15.4%) | 35 (16.8%) | 0.653 | | Induction of labor, secondary to GDM (, %) | 81 (20.5%) | 82 (39.4%) | <0.01 | | 5-minute (, %) | 385 (97.2%) | 204 (98.1%) | 0.513 | | Birthweight () | | | 0.051 | | SGA (, %) | 7 (1.8%) | 2 (1.0%) | 0.435 | | AGA (, %) | 263 (66.4%) | 156 (75.0%) | 0.029 | | LGA (, %) | 126 (31.8%) | 50 (24.0%) | 0.046 | | Gestational hypertension (, %) | 7 (1.9%) | 5 (2.4%) | 0.595 | | Preeclampsia (, %) | 27 (6.8%) | 13 (6.3%) | 0.79 | | Severe preeclampsia (, %) | 6 (1.5%) | 2 (1.0%) | 0.572 | | Shoulder dystocia (, %) | 17 (4.3%) | 9 (4.3%) | 0.984 | | Intrauterine growth restriction (, %) | 8 (2.0%) | 2 (1.0%) | 0.333 | | NICU admission (, %) | 51 (12.9%) | 33 (15.9%) | 0.328 | | Neonatal hypoglycemia (, %) | 46 (11.6%) | 43 (20.7%) | <0.01 | | Neonatal hyperbilirubinemia, requiring phototherapy (, %) | 20 (5.1%) | 14 (6.7%) | 0.395 | | Neonatal RDS (, %) | 20 (5.1%) | 15 (7.2%) | 0.306 | | Macrosomia (, %) | 58 (14.6%) | 20 (9.6%) | 0.064 |
|
|
